Insulin dynamics of breast- or formula-fed overweight and obese children

Melania Manco1, Arianna Alterio, Elisabetta Bugianesi

  • 1Scientific Directorate and Liver Unit, Paediatric Hospital Bambino Gesu` and Research Institute. Rome melaniamanco@tiscali.it

Insights

Formula feeding in early childhood is linked to reduced insulin sensitivity and increased insulin secretion in overweight and obese children. Breastfeeding appears to support better insulin metabolism in these children.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Nutritional Science

Background:

  • Early feeding practices significantly influence child development and metabolic health.
  • Overweight and obesity in childhood are associated with metabolic disturbances, including insulin resistance.

Purpose of the Study:

  • To investigate the association between early infant feeding type (breastfeeding vs. formula feeding) and insulin metabolism indices.
  • To assess insulin sensitivity and secretion in 8-year-old overweight and obese children based on their early feeding history.

Main Methods:

  • A study involving 350 overweight/obese children and 33 normal-weight controls, categorized by exclusive breastfeeding or formula feeding for at least 4 months.
  • Insulin sensitivity and secretion parameters were evaluated using 120-minute oral glucose tolerance tests.

Main Results:

  • Formula-fed overweight/obese children exhibited significantly lower insulin sensitivity compared to breast-fed counterparts.
  • Despite similar obesity levels, formula-fed children showed increased insulin secretion to compensate for insulin resistance.
  • Formula feeding was associated with greater catch-up growth in infancy.

Conclusions:

  • Formula feeding, compared to breastfeeding, is associated with diminished insulin sensitivity and heightened insulin secretion in overweight and obese children.
  • These findings suggest potential long-term metabolic implications of early feeding choices in at-risk children.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...